Analytics, News, and Forecasts for CFD Markets: stock news — 04-05-2021.

U.S. stock-index futures fell on Tuesday, as tech stocks remained under pressure amid ongoing rotation into value stocks.

Global Stocks:

(company / ticker / price / change ($/%) / volume)

McDonald's (MCD) target raised to $260 from $250 at Telsey Advisory Group

Bank of America (BAC) downgraded to Neutral from Outperform at Robert W. Baird; target $42

Boeing (BA) upgraded to Mkt Perform from Underperform at Bernstein; target raised to $229

FXStreet notes that S&P 500 closed the week back below 4200 on Friday. With another neutral session on Monday, economists at Credit Suisse believe the market remains in a consolidation phase, which it is expected to persist going forwards.

“The S&P 500 reversed to close back below our Q2 objective of 4200 on Friday. With a range of ‘red flags’ and overextension signals still in place, including OnBalanceVolume still not confirming the new highs and a growing bearish momentum divergence, we still do not look to chase strength beyond here for now.” 

“We look for a continuation of the recent consolidative range and further sideways ranging. Support remains at 4176/75 initially, which now includes the 13-day exponential average. A close below here would suggest a deeper corrective setback and a lengthier sideways phase, with support seen next at 4124.”

“Only below the 4118 recent low though would mark a near-term top.”

Pfizer (PFE) reported Q1 FY 2021 earnings of $0.93 per share (versus $0.80 per share in Q1 FY 2020), beating analysts’ consensus estimate of $0.78 per share.

The company’s quarterly revenues amounted to $14.582 bln (+44.6% y/y), beating analysts’ consensus estimate of $13.408 bln.

The company also issued upside guidance for FY 2021, projecting EPS of $3.55-3.65 versus analysts’ consensus estimate of $3.23 and prior guidance of $3.10-3.20 and revenues of $70.5-72.5 bln versus analysts’ consensus estimate of $60.17 bln and prior guidance of $59.4-61.4 bln.

PFE rose to $40.60 (+1.93%) in pre-market trading.

DuPont (DD) reported Q1 FY 2021 earnings of $0.91 per share (versus $0.84 per share in Q1 FY 2020), beating analysts’ consensus estimate of $0.76 per share.

The company’s quarterly revenues amounted to $3.976 bln (-23.8% y/y), beating analysts’ consensus estimate of $3.821 bln.

The company issued upside guidance for Q2 FY 2021, projecting EPS of $0.93-0.95 versus analysts' consensus estimate of $0.89 and revenues of $3.98-4.08 bln versus analysts' consensus estimate of $3.83 bln. DuPont also raised guidance for the full FY 2021: it now sees EPS of $3.60-3.75 compared to $3.30-3.45 previously and analysts' consensus estimate of $3.46 and revenues of $15.7-15.9 bln compared to $15.39-15.59 bln previously and analysts' consensus estimate of $15.45 bln.

DD rose to $78.89 (+0.78%) in pre-market trading.